Disease Mongering (Pseudo-Disease Promotion)
Detaljna analiza
15-11-2012
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.
Detaljna analiza
Informacije o dokumentu
Vrsta publikacije
Podnositelj
Područje politike
Ključna riječ
- DRUŠTVENA PITANJA
- Europska agencija za medicinske proizvode
- EUROPSKA UNIJA
- farmaceutska industrija
- farmaceutski proizvod
- institucije EU-a i europska javna služba
- javno zdravstvo
- potrošnja
- radno pravo i radni odnosi
- sprečavanje bolesti
- sukob interesa
- TRGOVINA
- ZAPOŠLJAVANJE I RADNI UVJETI
- zaštita potrošača
- zdravlje
- zdravstvena usluga